Tag Archives: HIV/AIDS

Antibiotics Discovery: Time for a ‘Manhattan Project’

by Susan Crowley The innovative pharmaceutical industry is under attack from critics around the world for failing to develop new antibiotics to treat emerging infections. The charge has been furthered by statements from World Health Organization (WHO) director Margaret Chan. In 2012, she warned that bacteria were starting to become so resistant to common antibiotics […]
Posted in Corporate Responsibility, Global, Guest Blog, healthcare, IP, leadership, Manufacturing, Market Access, R&D, Strategy | Also tagged , , , , , , | 4 Comments

Challenges in the March Toward an AIDS-Free Generation

FDA’s approval of Truvada, a once-a-day oral combination of tenofovir and emtricitabine, for pre-exposure prophylaxis (or PrEP, a method for preventing HIV infection) arrived during a chorus of optimism surrounding major developments in the fight against AIDS.
Posted in Biotech, Events, FDA, healthcare, Market Access, Patient Communication, patient compliance, patient education, pricing, Regulatory, Safety | Also tagged , , , , , , | Leave a comment

Affordable Access to HIV Meds on the Way

UNITAID’s Medicines Patent Pool seeks to bring costly HIV/AIDS treatments and other essential drugs to low-income countries by requiring patent-holders to license their technologies to generics manufacturers. Will pledges of support from the NIH bring some of these patent-holders back to the negotiating table? A new way for patients to have access to affordable HIV […]
Posted in Deals, Manufacturing | Also tagged , , | Leave a comment
  • Categories

  • Meta